Trump administration will allow pharmacies to make popular peptides

The Department of Health and Human Services will allow small compounding pharmacies to produce six peptides not yet approved by the FDA. The move aims to increase access, but experts warn it may not meet demand. The decision comes amid growing interest in these treatments and could face regulatory scrutiny.